Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data
Ruoqi Liu, Lai Wei, Ping Zhang
Nature Machine Intelligence (2021) Vol. 3, Iss. 1, pp. 68-75
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

AI-powered therapeutic target discovery
Frank W. Pun, Ivan V. Ozerov, Alex Zhavoronkov
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 561-572
Open Access | Times Cited: 146
Machine Learning Applications in Drug Repurposing
Fan Yang, Qi Zhang, Xiaokang Ji, et al.
Interdisciplinary Sciences Computational Life Sciences (2022) Vol. 14, Iss. 1, pp. 15-21
Open Access | Times Cited: 72
Deep learning in image-based phenotypic drug discovery
Daniel Krentzel, Spencer Shorte, Christophe Zimmer
Trends in Cell Biology (2023) Vol. 33, Iss. 7, pp. 538-554
Open Access | Times Cited: 52
Artificial intelligence in drug development
Kang Zhang, Xin Yang, Yifei Wang, et al.
Nature Medicine (2025) Vol. 31, Iss. 1, pp. 45-59
Closed Access | Times Cited: 18
NerLTR-DTA: drug–target binding affinity prediction based on neighbor relationship and learning to rank
Xiaoqing Ru, Xiucai Ye, Tetsuya Sakurai, et al.
Bioinformatics (2022) Vol. 38, Iss. 7, pp. 1964-1971
Closed Access | Times Cited: 43
Multitask joint strategies of self-supervised representation learning on biomedical networks for drug discovery
Xiaoqi Wang, Yingjie Cheng, Yaning Yang, et al.
Nature Machine Intelligence (2023) Vol. 5, Iss. 4, pp. 445-456
Open Access | Times Cited: 31
High-throughput target trial emulation for Alzheimer’s disease drug repurposing with real-world data
Chengxi Zang, Hao Zhang, Jie Xu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
A deep learning system for myopia onset prediction and intervention effectiveness evaluation in children
Ziyi Qi, Tingyao Li, Jun Chen, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data
Chang Su, Yu Hou, Jielin Xu, et al.
npj Digital Medicine (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Revolutionizing adjuvant development: harnessing AI for next-generation cancer vaccines
Wei Zhang, Xiaoli Zheng, Paolo Coghi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Deep learning and generative artificial intelligence in aging research and healthy longevity medicine
Dominika Wilczok
Aging (2025)
Open Access | Times Cited: 1
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease
Yunxiao Ren, Andrew A. Pieper, Feixiong Cheng
Neurotherapeutics (2025), pp. e00553-e00553
Open Access | Times Cited: 1
Applications of Artificial Intelligence in Drug Repurposing
Zhaoman Wan, Xinran Sun, Yi Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Deep learning in target prediction and drug repositioning: Recent advances and challenges
Junlin Yu, Qing-Qing Dai, Guo‐Bo Li
Drug Discovery Today (2021) Vol. 27, Iss. 7, pp. 1796-1814
Open Access | Times Cited: 53
Success stories of AI in drug discovery - where do things stand?
Kit‐Kay Mak, Madhu Katyayani Balijepalli, Mallikarjuna Rao Pichika
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 1, pp. 79-92
Closed Access | Times Cited: 43
A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 699-721
Open Access | Times Cited: 38
Computational drug repurposing based on electronic health records: a scoping review
Nansu Zong, Andrew Wen, Sungrim Moon, et al.
npj Digital Medicine (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 35
Harnessing the potential of machine learning and artificial intelligence for dementia research
Janice M. Ranson, Magda Bucholc, Donald M. Lyall, et al.
Brain Informatics (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 17
Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network
Jiannan Yang, Zhen Li, William Ka Kei Wu, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 6
Closed Access | Times Cited: 24
Biomedical discovery through the integrative biomedical knowledge hub (iBKH)
Chang Su, Yu Hou, Manqi Zhou, et al.
iScience (2023) Vol. 26, Iss. 4, pp. 106460-106460
Open Access | Times Cited: 15
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Fengcheng Li, Minjie Mou, LI Xiao-yi, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1372-D1382
Open Access | Times Cited: 6
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
Large Language Model-Based Natural Language Encoding Could Be All You Need for Drug Biomedical Association Prediction
Hanyu Zhang, Yuan Zhou, Zhichao Zhang, et al.
Analytical Chemistry (2024)
Closed Access | Times Cited: 5
Drug repositioning: A bibliometric analysis
Guojun Sun, Dashun Dong, Zuojun Dong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Artificial intelligence for dementia prevention
Danielle Newby, Vasiliki Orgeta, Charles R. Marshall, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 12, pp. 5952-5969
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top